As of August 28, 2026, Polaryx Therapeutics, Inc. (PLYX) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. Polaryx Therapeutics, Inc. has a market capitalization of $163.00M, 49.85M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for PLYX.
Market Data
Market Cap$163.00M
Shares Outstanding49.85M
Float4.28M
Cash$11.54M
DebtN/A
Short InterestN/A
Institutional Holdings
4.5% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest256.8K
Days to Cover2.5
% of Float6.0%
FINRA data as of Jul 31, 2026
Recent SEC Activity
8-K
8K EVENT
2026-05-28
4
INSIDER TRANSACTION
2026-05-28
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual PLYX Dilution Snapshot
Polaryx Therapeutics, Inc. (PLYX) has a DilutionScore of 47/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for PLYX: 8-K on 2026-05-28; 4 on 2026-05-28.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track PLYX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PLYX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for PLYX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.